These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical development of antisense oligonucleotides as anti-cancer therapeutics. Chen HX Methods Mol Med; 2003; 75():621-36. PubMed ID: 12407768 [No Abstract] [Full Text] [Related]
5. Therapeutic targeting of the p53 tumor suppressor gene. Beaudry GA; Bertelsen AH; Sherman MI Curr Opin Biotechnol; 1996 Dec; 7(6):592-600. PubMed ID: 8939636 [TBL] [Abstract][Full Text] [Related]
6. Cancer gene therapy. Douglas JT Technol Cancer Res Treat; 2003 Feb; 2(1):51-64. PubMed ID: 12625754 [TBL] [Abstract][Full Text] [Related]
7. New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy. Bao J; Qiao L Cancer Lett; 2017 Feb; 387():1-2. PubMed ID: 28038727 [No Abstract] [Full Text] [Related]
8. Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy. Romano G; Kwong LN Cancer Metastasis Rev; 2018 Mar; 37(1):45-53. PubMed ID: 29270700 [TBL] [Abstract][Full Text] [Related]
10. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
11. From correlation to causality: microarrays, cancer, and cancer treatment. O'Neill GM; Catchpoole DR; Golemis EA Biotechniques; 2003 Mar; Suppl():64-71. PubMed ID: 12664688 [No Abstract] [Full Text] [Related]
12. Antibody Therapies in Cancer. Wang S; Jia M Adv Exp Med Biol; 2016; 909():1-67. PubMed ID: 27240456 [TBL] [Abstract][Full Text] [Related]
13. [Basics of molecular diagnostics and therapy of malignant tumors]. Daniel PT; Dörken B Internist (Berl); 2005 Aug; 46(8):835-6, 838-42, 844-6. PubMed ID: 16010519 [TBL] [Abstract][Full Text] [Related]
14. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide. Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Tortora G J Natl Cancer Inst; 1998 Jul; 90(14):1087-94. PubMed ID: 9672257 [TBL] [Abstract][Full Text] [Related]
15. Folate-Modified Lipoplexes Delivering the Interleukin-12 Gene for Targeting Colon Cancer Immunogene Therapy. Luo M; Liang X; Luo ST; Wei XW; Liu T; Ren J; Ma CC; Yang YH; Wang BL; Liu L; Song XR; He ZY; Wei YQ J Biomed Nanotechnol; 2015 Nov; 11(11):2011-23. PubMed ID: 26554159 [TBL] [Abstract][Full Text] [Related]
16. Synthetic lethal vulnerabilities of cancer. Fece de la Cruz F; Gapp BV; Nijman SM Annu Rev Pharmacol Toxicol; 2015; 55():513-31. PubMed ID: 25340932 [TBL] [Abstract][Full Text] [Related]
17. Targeting transcription factors: promising new strategies for cancer therapy. Yeh JE; Toniolo PA; Frank DA Curr Opin Oncol; 2013 Nov; 25(6):652-8. PubMed ID: 24048019 [TBL] [Abstract][Full Text] [Related]
18. Cancer gene therapy targeting cellular apoptosis machinery. Jia LT; Chen SY; Yang AG Cancer Treat Rev; 2012 Nov; 38(7):868-76. PubMed ID: 22800735 [TBL] [Abstract][Full Text] [Related]
19. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver? Kortylewski M; Nechaev S Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948 [No Abstract] [Full Text] [Related]